Canton Barry
Canton Barry, 10%, reported an open-market or private sale at Ginkgo Bioworks Holdings, Inc. involving 18803.000000 shares for an estimated $190718.83. Reported holdings after the transaction were 356329.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 19, 2026
- Filing date
- Oct 21, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 375,132 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
DNA price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001628280-26-066705 Class A Common Stock
- Transaction date
- Oct 19, 2026 Filed Oct 21, 2026, 08:06 PM · 2d delay
- Shares
- 18,803 sh $10.14 per share
- Estimated value
- -$190k Computed from shares × price
- Holdings after
- 356,329 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F2
Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obl…
- F3
The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% vested on October 16, 2026 and 25% will vest on January 21, 2027.
- F4
The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters.
0 other transactions
0 recent txs